Table 2.

Baseline stroke severity and in-hospital outcome of patients with acute ischemic stroke treated with t-PA

Variablet-PA Survey, n = 189NINDS Trial, Parts I, II, t-PA arms, %
Missing data are excluded from analysis.
* Mean length of stay (±SD) was 10 ± 10 days in survey and 11 ± 10 days in the t-PA arms of the NINDS trial.
† Assessed at discharge in survey and at 7–10 days from randomization in the NINDS trial.
t-PA = tissue plasminogen activator; NIHSS = National Institutes of Health Stroke Scale; NP = not published.
Baseline NIHSS scores, n (%)
≤521 (11)14
6–1044 (23)22
11–1547 (25)21
16–2049 (26)23
>2026 (14)20
Length of stay, d, median (range)*7 (1, 84)NP
In-hospital mortality, n (%)18 (10)11
Modified Rankin scale, n (%)
0–157 (34)35
2–354 (32)19
4–556 (34)46
Disposition, n (%)
Home77 (46)57
Rehabilitation79 (47)34
Nursing home12 (7)8